Endo International PLC (ENDPQ)
0.0006
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Endo International Cash from Investing (Quarterly): -11.65M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.65M |
| September 30, 2023 | -6.244M |
| June 30, 2023 | -10.54M |
| March 31, 2023 | -21.36M |
| December 31, 2022 | 1.399M |
| September 30, 2022 | -22.80M |
| June 30, 2022 | -62.90M |
| March 31, 2022 | -48.84M |
| December 31, 2021 | 10.80M |
| September 30, 2021 | -25.30M |
| June 30, 2021 | -28.00M |
| March 31, 2021 | -17.05M |
| December 31, 2020 | -579.36M |
| September 30, 2020 | -18.82M |
| June 30, 2020 | -15.45M |
| March 31, 2020 | -15.96M |
| December 31, 2019 | -14.87M |
| September 30, 2019 | -23.01M |
| June 30, 2019 | -5.939M |
| March 31, 2019 | -16.38M |
| December 31, 2018 | -4.218M |
| September 30, 2018 | -4.694M |
| June 30, 2018 | 6.609M |
| March 31, 2018 | -15.60M |
| December 31, 2017 | 95.62M |
| Date | Value |
|---|---|
| September 30, 2017 | 50.16M |
| June 30, 2017 | -30.21M |
| March 31, 2017 | -10.98M |
| December 31, 2016 | -356.42M |
| September 30, 2016 | 41.86M |
| June 30, 2016 | 105.94M |
| March 31, 2016 | 31.07M |
| December 31, 2015 | -223.27M |
| September 30, 2015 | -5.054B |
| June 30, 2015 | 24.14M |
| March 31, 2015 | -930.48M |
| December 31, 2014 | -393.01M |
| September 30, 2014 | -967.18M |
| June 30, 2014 | -53.46M |
| March 31, 2014 | 641.80M |
| December 31, 2013 | -756.65M |
| September 30, 2013 | -73.64M |
| June 30, 2013 | -16.06M |
| March 31, 2013 | -37.29M |
| December 31, 2012 | -9.31M |
| September 30, 2012 | -46.99M |
| June 30, 2012 | 1.75M |
| March 31, 2012 | -33.92M |
| December 31, 2011 | -6.904M |
| September 30, 2011 | 1.406M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-579.36M
Minimum
Dec 2020
10.80M
Maximum
Dec 2021
-48.21M
Average
-17.05M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Alkermes PLC | -20.98M |
| Jazz Pharmaceuticals PLC | 101.80M |
| Medtronic PLC | -707.00M |
| Perrigo Co PLC | -22.80M |
| Iterum Therapeutics PLC | 13.52M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 115.06M |
| Cash from Financing (Quarterly) | -149.76M |
| Free Cash Flow | 340.77M |
| Free Cash Flow Per Share (Quarterly) | 0.4038 |
| Free Cash Flow to Equity (Quarterly) | 7.484B |
| Free Cash Flow to Firm (Quarterly) | 94.98M |
| Free Cash Flow Yield | 241.5K% |